Globeflex Capital L P Neurocrine Biosciences Inc Transaction History

Globeflex Capital L P

$592 Million
Q3 2025

A detailed history of Globeflex Capital L P transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Globeflex Capital L P holds 29,514 shares of NBIX stock, worth $4.28 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

29,514

Previous 28,457 3.71%

Holding current value

$4.28 Million

Previous $3.58 Million 15.86%

% of portfolio

0.7%

Previous 0.31%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$123.98 - $146.67 $131,046 - $155,030	1,057 Added 3.71%	29,514 $4.14 Million
Q2 2025 Aug 14, 2025	BUY	$87.54 - $128.18 $547,562 - $801,765	6,255 Added 28.17%	28,457 $3.58 Million
Q1 2025 May 12, 2025	SELL	$107.22 - $153.29 $128,878 - $184,254	-1,202 Reduced 5.14%	22,202 $2.46 Million
Q4 2024 Feb 10, 2025	BUY	$111.62 - $139.44 $134,167 - $167,606	1,202 Added 5.41%	23,404 $3.19 Million
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $80,549 - $107,664	703 Added 3.27%	22,202 $2.56 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $188,045 - $205,764	-1,437 Reduced 6.27%	21,499 $2.96 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $188,910 - $236,445	1,781 Added 8.42%	22,936 $3.02 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $350,151 - $410,146	-3,911 Reduced 15.6%	21,155 $1.99 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $736,693 - $963,000	7,828 Added 45.41%	25,066 $2.54 Million
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $609,157 - $725,258	5,708 Added 49.51%	17,238 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $1.06 Million - $1.24 Million	11,530 New	11,530 $1.23 Million
Q4 2020 Feb 11, 2021	SELL	$86.91 - $108.33 $489,477 - $610,114	-5,632 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $96,063 - $135,014	-999 Reduced 15.07%	5,632 $542,000
Q2 2020 Aug 12, 2020	SELL	$85.09 - $130.36 $224,382 - $343,759	-2,637 Reduced 28.45%	6,631 $809,000
Q4 2019 Feb 07, 2020	BUY	$86.8 - $118.57 $804,462 - $1.1 Million	9,268 New	9,268 $996,000

Others Institutions Holding NBIX

# of Institutions

718

Shares Held

102M

Call Options Held

228K

Put Options Held

336K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account

Globeflex Capital L P Neurocrine Biosciences Inc Transaction History